International Chinese Media Alliance and Municipal Federation of Overseas Chinese Visit

Release time:

2024-01-17


On January 17, 2024, Chairman Wang Yongxin and Chairman Huang Bei of Zhenjiang Overseas Chinese Federation, Chairman Xu Bingyi and Chairman Zhang Qin of the International Chinese Media Alliance visited Jiangsu 707 Natural Pharmaceutical Co., Ltd. to communicate with Chairman Geng Tongquan and Trade Union Chairman Cheng Jimin on the development of enterprises and the Chinese medicine industry.

On January 17, 2024, Chairman Wang Yongxin and Chairman Huang Bei of Zhenjiang Overseas Chinese Federation, Chairman Xu Bingyi and Chairman Zhang Qin of the International Chinese Media Alliance visited Jiangsu 707 Natural Pharmaceutical Co., Ltd. to communicate with Chairman Geng Tongquan and Trade Union Chairman Cheng Jimin on the development of enterprises and the Chinese medicine industry.

In this activity, the marketing manager Mao Ning introduced the current situation of the enterprise and the core products to the guests. Chairman Geng Tongquan and trade union chairman Cheng Jimin had an in-depth exchange with the guests on the historical inheritance and innovation of Jinshan brand Zhenjiang Plaster, our leading product, and shared in detail the [Zhenjiang Plaster] traditional Chinese medicine pain-dispelling characteristic therapy system with Jinshan brand Zhenjiang Plaster as the core.

During the exchange, the participating experts and leaders jointly discussed how to integrate and use relevant resources in the current situation to help the communication and development of enterprises and brands.

Xu Bingyi, chairman of the International Chinese Media Alliance, said: "We need to tell the story of Zhenjiang Plaster, make this product with a long history and exact curative effect known to more people, and constantly open up the popularity of the brand and products." so that more consumers suffering from pain and illness benefit."

Chairman Geng Tongquan said: "Seventy-seven Natural Pharmaceuticals has always taken care of human health as its goal, and will further utilize its product advantages in the future. Relying on the Seventy-seven Institute of Traditional Chinese Medicine Pain and Bone Injury, it will accelerate the construction of clinical, inheritance, and teaching bases. Let the Chinese medicine culture continue to develop in the inheritance."

In the future, Seventy-Seven Natural Pharmaceuticals will continue to uphold the concept of inheriting the essence and keeping integrity and innovation, enhance product advantages, strengthen brand building, and contribute to the prosperity and development of the industry.